Order Article Reprints

Krauze AV, Zhao Y, Li M-C, Shih J, Jiang W, Tasci E, Cooley Zgela T, Sproull M, Mackey M, Shankavaram U, et al. Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation. Biomolecules. 2023; 13(10):1499. https://doi.org/10.3390/biom13101499

Krauze, Andra V., Yingdong Zhao, Ming-Chung Li, Joanna Shih, Will Jiang, Erdal Tasci, Theresa Cooley Zgela, Mary Sproull, Megan Mackey, Uma Shankavaram, and et al. 2023. "Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation" Biomolecules 13, no. 10: 1499. https://doi.org/10.3390/biom13101499

Krauze, A. V., Zhao, Y., Li, M.-C., Shih, J., Jiang, W., Tasci, E., Cooley Zgela, T., Sproull, M., Mackey, M., Shankavaram, U., Tofilon, P., & Camphausen, K. (2023). Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation. Biomolecules, 13(10), 1499. https://doi.org/10.3390/biom13101499